“…Indeed, almost all USH3A patients develop normal speech, and, although an elevation of hearing thresholds is diagnosed in most patients before the age of 10 years, some patients display only mild to moderate hearing threshold elevation at the time of detection, at an age of 30-40 years (42,43). The discrepancy in hair cell phenotype between humans (42, 43) and Clrn1 total knockout mice (7,11) suggests that compensatory mechanisms, possibly involving genes encoding other members of the clarin family (CLRN2 and CLRN3), operate much more efficiently, particularly during embryogenesis and early postnatal development, in humans than in mice. USH1 and USH2 patients present congenital hearing loss.…”